Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: procedure (650), etiquette (1), practice (609)

DasatinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications Regimen • CML – Dasatinib (chronic phase) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf

DasatinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (accelerated phase) Funding may be required for specific indications Regimen • CML – Dasatinib (accelerated phase) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibAccelerated.pdf

Bosutinib

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Bosutinib Regimen • Bosutinib Indication • As an option for the treatment of patients with chronic phase, accelerated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Bosutinib.pdf

Lomustine-Procarbazine ver 1.1

Description: Chemotherapy Protocol Central Nervous System LOMUSTINE-PROCARBAZINE Regimen CNS – Lomustine-Procarbazine Indication Adjuvant treatment for grade III gliomas including anaplastic astrocytoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Lomustine-Procarbazine-ver-1.1.pdf

Capecitabine 1250 (14)

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE 1250 (14 day) Regimen • Breast Cancer – Capecitabine 1250 (14 day) Indication • Treatment of locally advanced or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1250-14.pdf

Capecitabine 1000 (14)

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE 1000 (14 day) Regimen • Breast Cancer – Capecitabine 1000 (14 day) Indication • Treatment of locally advanced or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1000-14.pdf

Topotecan (Oral)

Description: Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) TOPOTECAN (Oral) Regimen • SCLC – Topotecan PO Indication • Treatment of relapsed SCLC when re-treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Topotecan-Oral.pdf

Vinorelbine Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER VINORELBINE (INTRAVENOUS) Regimen Breast Cancer – Vinorelbine Indication Treatment of locally advanced or metastatic breast cancer that has
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Vinorelbine-Ver-1.1.pdf

Vinorelbine PO (day 1, 8, 15) Ver 1.2

Description: Chemotherapy Protocol BREAST CANCER VINORELBINE Oral (Day 1, 8, 15) Regimen Breast Cancer – Vinorelbine Oral (day 1, 8, 15) Indication Treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Vinorelbine-PO-day-1-8-15-Ver-1.2.pdf

Paclitaxel Albumin Bound (Abraxane)

Description: Chemotherapy Protocol BREAST CANCER PACLITAXEL ALBUMIN BOUND Regimen • Breast Cancer – Paclitaxel Albumin Bound Indication • Paclitaxel albumin bound can be prescribed where
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-Albumin-Bound-Abraxane.pdf

401 to 410 of 698

Previous … 39 40 41 42 43 … Next